IPO registrations (S-1, F-1) · Registrants
MAXYGEN INC
- SEC CIK
- 1068796 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1999-10-20, last 2000-03-10; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 1999-12-17
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 411 BOREL AVENUE, SUITE 616, San Mateo, CA 94402
- EIN
- 77-0449487
- EDGAR entity type
- operating
- Insiders and CEO pay
- MAXYGEN INC on the corporate pages
Offering terms
- Proposed price range
- $13.00–$15.00 per share (S-1/A filed 1999-12-15)
- Final price
- $16.00 per share, above the range (424B4 filed 1999-12-17, an initial public offering)
- Shares sold
- 6,000,000
- Gross proceeds
- $96,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MAXY
- Lead underwriters
- Goldman Sachs; Robertson Stephens (1,522,500 shares); Invemed Associates (1,015,000 shares)
- Syndicate
- RBC Capital Markets (65,000); First Security Van Kasper (65,000); Hambrecht & Quist (100,000); Edward D. Jones & Co., L.P (100,000); Merrill Lynch (100,000); Pacific Growth Equities, Inc (65,000); Prudential Securities (100,000); Punk, Ziegel & Company, L.P (65,000); Citigroup (100,000); UBS (100,000); Wit Capital (65,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: MAXYGEN, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: MAXYGEN, INC. EXACT (EIN (EXACT))
- Federal award recipient: MAXYGEN, INC. Fuzzy (name and state)
- Lobbying client: MAXYGEN, INC. Fuzzy (name and state)
- SEC filer: MAXYGEN INC EXACT (CIK (EXACT))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1999-10-20 | S-1 | S-1 (registration) | MAXYGEN INC | 0001012870-99-003763 ↗ |
| 1999-11-22 | S-1/A | S-1/A (amendment) | MAXYGEN INC | 0000950109-99-004202 ↗ |
| 1999-12-15 | S-1/A | S-1/A (amendment) | MAXYGEN INC | 0001012870-99-004648 ↗ |
| 1999-12-16 | S-1MEF | S-1MEF (added securities) | MAXYGEN INC | 0001012870-99-004667 ↗ |
| 1999-12-17 | 424B4 | 424B4 (final prospectus) | MAXYGEN INC | 0001012870-99-004681 ↗ |
| 2000-03-03 | S-1 | S-1 (registration) | MAXYGEN INC | 0000898430-00-000639 ↗ |
| 2000-03-10 | S-1/A | S-1/A (amendment) | MAXYGEN INC | 0001012870-00-001304 ↗ |
| 2000-03-21 | 424B4 | 424B4 (final prospectus) | MAXYGEN INC | 0001012870-00-001480 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1999-12-15 | S-1/A | registration statement | $13.00–$15.00 | 5,500,000 | - | Nasdaq MAXY | 7 | from the submission text; range, price line, shares headline, proceeds computed, price outside the range dropped, underwriting table 4, cover names 3 | document ↗ | |
| 1999-12-17 | 424B4 | final prospectus | $16.00 | 6,000,000 | $96,000,000 | Nasdaq MAXY | 14 | from the submission text; price sentence, shares headline, proceeds table, underwriting table 13, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BRISCOE LAWRENCE W | Officer | Senior Vice President and CFO | 11 | 2006–2009 | |
| GOLDSTEIN ELLIOT | Officer | Chief Operating Officer | 11 | 2006–2009 | |
| HOWARD RUSSELL J | Director,Officer | Chief Executive Officer | 56 | 2006–2009 | |
| RABSON MICHAEL | Officer | Senior Vice President | 7 | 2006–2008 | |
| RINGOLD GORDON | Director; Director,TenPercentOwner | 36 | 2006–2012 | ||
| STEIN ISAAC | Director | 12 | 2006–2013 | ||
| GREENWOOD MRC | Director | 3 | 2006–2008 | ||
| MARIO ERNEST | Director | 7 | 2006–2012 | ||
| SULAT JAMES R | Director; Director,Officer | CEO & CFO; Former CEO & CFO | 6 | 2006–2013 | |
| Vetticaden Santosh | Officer | Chief Medical Officer; Senior Vice President | 6 | 2007–2008 | |
| LANGE LOUIS G | Director | 6 | 2007–2012 | ||
| Yonehiro Grant | Officer | Chief Business Officer; Senior Vice President | 13 | 2008–2011 | |
| CONUS PARTNERS INC | TenPercentOwner | 9 | 2008–2010 | ||
| ZACKS ANDREW | TenPercentOwner | 9 | 2008–2010 | ||
| LEE KENNETH B JR | Director | 5 | 2009–2012 | ||
| GLAXOSMITHKLINE PLC | TenPercentOwner | 1 | 2010 | ||
| Borkholder John | Officer | General Counsel & Secretary | 7 | 2011–2013 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | MAXYGEN, INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| SEC filer | MAXYGEN INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | MAXYGEN, INC. | EIN (EXACT) | ||
| Federal award recipient | MAXYGEN, INC. | Federal spending (USAspending) | name and state | |
| Lobbying client | MAXYGEN, INC. | Federal lobbying (LDA) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, CA first:
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- SIGNAL PHARMACEUTICALS INC CA
- DELTAGEN INC CA
- KOSAN BIOSCIENCES INC CA
- CytoCore, Inc. CA
- diaDexus, Inc. (pre-merger) CA
- SENOMYX INC CA
- DNA SCIENCES INC CA
- KINEMED INC CA
In other datasets, the same topic (Medical research) in CA:
- Nonprofit: 23ANDME RESEARCH INSTITUTE (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research